These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 7682261)

  • 21. [Evaluation of treatment and management of Kawasaki coronary artery disease based on clinical severity classification].
    Liu F; Zhao L; Wu L; Liang X; Chu C; He L; Huang G
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):690-5. PubMed ID: 26757970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
    Miura M; Ohki H; Tsuchihashi T; Yamagishi H; Katada Y; Yamada K; Yamashita Y; Sugaya A; Komiyama O; Shiro H
    Arch Dis Child; 2004 Aug; 89(8):776-80. PubMed ID: 15269082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two-dimensional echocardiographic study of coronary artery lesion in Kawasaki disease: a new approach to visualize the right coronary artery].
    Ichinose E; Eto Y; Takechi T; Yoshioka F; Kato H
    J Cardiogr; 1982 Mar; 12(1):111-24. PubMed ID: 7119487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of coronary aneurysms in patients with Kawasaki syndrome.
    Takahashi M; Mason W; Lewis AB
    Circulation; 1987 Feb; 75(2):387-94. PubMed ID: 3802442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease.
    Haneda N; Mori C
    Acta Paediatr Jpn; 1993 Aug; 35(4):294-7. PubMed ID: 7691025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiographic evaluation of coronary artery lesions due to Kawasaki disease-natural history and coronary artery obstruction].
    Takahashi N
    Fukuoka Igaku Zasshi; 1995 Mar; 86(3):92-8. PubMed ID: 7750895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
    Ruan Y; Ye B; Zhao X
    Pediatr Infect Dis J; 2013 Oct; 32(10):e397-402. PubMed ID: 23722531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Two-dimensional echocardiography of coronary artery in Kawasaki disease (MCLS): detection, changes in acute phase, and follow-up observation of the aneurysm (author's transl)].
    Hirose O; Misawa H; Kijima Y; Yamada O; Arakaki Y; Kajino Y; Ryujin Y; Kowata T; Echigo S; Kamiya T
    J Cardiogr; 1981 Mar; 11(1):89-104. PubMed ID: 7264399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiac involvement in Kawasaki disease].
    Urcelay G; Hernández I; Farrú O; Arcil G; Godoy F
    Rev Chil Pediatr; 1989; 60(6):315-9. PubMed ID: 2520836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial analysis of regional left ventricular wall motion by two-dimensional echocardiography in patients with coronary artery enlargement after Kawasaki disease.
    Vogel M; Smallhorn JF; Freedom RM
    J Am Coll Cardiol; 1992 Oct; 20(4):915-9. PubMed ID: 1527302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Follow up and review of patients with Kawasaki disease complicated with giant coronary artery aneurysms for a decade: a single-institution experience].
    Zhang L; Yu M; Xie X; Huang P; Zhang M; Guo Y; Cao R; Gu X
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):40-4. PubMed ID: 25748403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of coronary artery aneurysm to obstructive lesion and the role of collateral vessels in myocardial perfusion in patients with Kawasaki disease.
    Onouchi Z; Hamaoka K; Kamiya Y; Hayashi S; Ohmochi Y; Sakata K; Shiraishi I; Hayano T; Fukumochi H
    J Am Coll Cardiol; 1993 Jan; 21(1):158-62. PubMed ID: 8417058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose gammaglobulin therapy for Kawasaki disease.
    Nagashima M; Matsushima M; Matsuoka H; Ogawa A; Okumura N
    J Pediatr; 1987 May; 110(5):710-2. PubMed ID: 2437278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Labeled WBC cardiac imaging and two-dimensional echocardiography to evaluate high-dose gamma globulin treatment in Kawasaki disease.
    Kao CH; Hsieh KS; Chen YC; Wang YL; Wang SJ; Yeh SH
    Clin Nucl Med; 1995 Sep; 20(9):813-6. PubMed ID: 8521660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.
    Rowley AH; Duffy CE; Shulman ST
    J Pediatr; 1988 Aug; 113(2):290-4. PubMed ID: 2456378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of pharmacological treatment of Kawasaki disease.
    Onouchi Z; Kawasaki T
    Drugs; 1999 Nov; 58(5):813-22. PubMed ID: 10595862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kawasaki disease: review of risk factors for coronary aneurysms.
    Koren G; Lavi S; Rose V; Rowe R
    J Pediatr; 1986 Mar; 108(3):388-92. PubMed ID: 3950818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New hope for children with Kawasaki disease.
    Lux KM
    J Pediatr Nurs; 1991 Jun; 6(3):159-65. PubMed ID: 1710660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular abnormalities in Kawasaki disease. An Italian prospective study].
    Salice P; Pietrogrande MC; Barbier P; Ghiglia S; Laicini E; Fesslova V
    Cardiologia; 1998 Dec; 43(12):1367-74. PubMed ID: 9988946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.